UBP 302 is an effective and selective GLUK5-subunit-containing kainatereceptor antagonist (apparent Kd=402 nM) and displays very little affinity on GluK2 kainatereceptors.
GYKI-52466 is a selective non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >50 μM for AMPA-, kainate- and NMDA-induced responses, respectively) used as a Skeletal muscle relaxant, orally active anticonvulsant, neuroprotective and
CP-465022 Maleate is a potent, selective, noncompetitive AMPA receptor antagonist with anticonvulsant activity. It effectively counters the Kainate-induced response in rat cortical neurons, exhibiting an IC 50 of 25 nM. As such, CP-465022 Maleate presents a valuable instrument for studying the involvement of AMPA receptors in various physiological and pathophysiological processes [1] [2].
AMPA receptor antagonist with weak activity at NMDA receptors and little activity at kainatereceptors.This compound is unstable in powder form and other related salt forms are recommended.